Nerve and Plane Block Data Collection Study for the Development of Artificial Intelligence-assisted Software
1 other identifier
observational
200
1 country
1
Brief Summary
The primary objective of this observational study is to acquire ultrasound images (raw data) from nerve and plane block regions to develop artificial intelligence-guided nerve block software (Nerveblox). The study aims to acquire raw ultrasound video from 200 volunteers' planned nerve and plane block regions. These participants will undergo ultrasound scans administered by expert clinicians proficient in these techniques in their clinical practice. The data collection devices utilized in this study are FDA-cleared general-purpose ultrasound devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 16, 2024
CompletedFirst Posted
Study publicly available on registry
April 19, 2024
CompletedApril 19, 2024
April 1, 2024
5 months
April 16, 2024
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of image quality
Collected images will be used for labeling anatomical landmarks for development of Nerveblox.
6 months
Interventions
Clinical experts will conduct non-invasive ultrasound scans from the specified nerve or plane block views and record the acquired data.
Eligibility Criteria
200 healthy volunteers will participate in the data collection study. Their weight, height, age, and gender information will be documented.
You may qualify if:
- Male at least 18 years of age
- Female at least 18 years of age
- Health volunteers
- Able to confirm and sign the Informed Consent Form before enrolment the study
You may not qualify if:
- Male below 18 years of age
- Female below 18 years of age
- Unwilling to participate or unable to sign an informed consent form
- Inability to lie flat
- Anatomical deformity in the area to be scanned for nerve and plane blocks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Smart Alfa Teknoloji San. ve Tic. A.S.lead
- Ankara Universitycollaborator
Study Sites (1)
Ankara University School of Medicine
Ankara, 06230, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Süheyla Karadağ Erkoç, Assoc. Prof.
Ankara University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2024
First Posted
April 19, 2024
Study Start
December 1, 2022
Primary Completion
May 1, 2023
Study Completion
May 1, 2023
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share